Stay updated on GMI-1271 Combo with Chemo in AML Clinical Trial

Sign up to get notified when there's something new on the GMI-1271 Combo with Chemo in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GMI-1271 Combo with Chemo in AML Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Difference
    1%
    Check dated 2025-04-23T22:24:42.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page has been updated to include new drug information related to acute myeloid leukemia, specifically mentioning Cytarabine and Idarubicin, while removing detailed descriptions of a clinical trial and its criteria.
    Difference
    14%
    Check dated 2025-04-16T14:44:44.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.6%
    Check dated 2025-04-09T09:57:09.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2025-03-25T14:15:21.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2025-03-11T04:49:52.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-02-24T21:18:24.000Z thumbnail image

Stay in the know with updates to GMI-1271 Combo with Chemo in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GMI-1271 Combo with Chemo in AML Clinical Trial page.